NCT06774989View on ClinicalTrials.gov

Real-life Pharmacological Monitoring of Encorafenib-Binimetinib in the Treatment of Metastatic Melanoma

RecruitingOBSERVATIONAL

Enrollment

66

Participants

Timeline

Start Date

January 2, 2025

Primary Completion Date

January 31, 2028

Study Completion Date

January 31, 2028

Conditions

Melanoma (Skin)

Trial Locations (1)

92100

RECRUITING

Department of Oncology-Dermatology, Ambroise Paré Hospital - APHP, Boulogne-Billancourt

All Listed Sponsors

lead

Assistance Publique - Hôpitaux de Paris

OTHER